Coverage
-
April 03, 2020
McKesson Corp. has sought another dismissal of a shareholder derivative action accusing the company of concealing its involvement in alleged pharmaceutical industry price-fixing, telling a California federal judge that the latest complaint didn't properly address the issues in the old one.
3 other articles on this case.
View all »